- Home
- / Suven Life Sciences
Suven Life Sciences
Stock Price
₹118.1
2024-10-29
Market Capitalization
₹28.4 B
2024-10-29
Revenue
₹71.1 M
FY, 2026
Suven Life Sciences Summary
Company Summary
- Overview
- Suven Life Sciences is a biopharmaceutical company specialized in NCE-based CRAMS. It focuses on drug discovery and development for the treatment of central nervous system disorders.
- Type
- Public
- Status
- Active
- Founded
- 1989
- HQ
- Hyderabad, IN | view all locations
- Website
- http://www.suven.com/
- Cybersecurity rating
- ESG rating
Table of Contents
Key People
Seyed E. Hasnain, Director
M Gopalakrishna, Director
Sudharani Jasti, Wholetime Director
LocationsView all
5 locations detected
Hyderabad, Telangana HQ
India
6th Floor, SDE Serene Chambers, Road No 7, Avenue 7, Banjara Hills
South Brunswick Township, NJ
United States
1100 Cornwall Rd, Monmouth Junction
Dasaigudem, Telangana
India
Hyderabad, TG
India
Phase 3 Rd, Madhura Nagar, Nizampet
Sangareddy, Telangana
India
Suven Life Sciences Financials
Summary Financials
- Revenue (FY, 2026)
- ₹71.1M
- Gross profit (FY, 2026)
- ₹210.4M
- Net income (FY, 2026)
- (₹2.8B)
- Cash (FY, 2026)
- ₹3.4B
- EBIT (FY, 2026)
- (₹2.8B)
- Enterprise value
- $25.2B